FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $480,782 | -34.7% | 146,580 | +46.0% | 0.00% | – |
| Q1 2024 | $736,789 | +22.5% | 100,380 | -37.6% | 0.00% | – |
| Q4 2023 | $601,242 | +75.5% | 160,760 | -0.5% | 0.00% | – |
| Q3 2023 | $342,507 | -43.4% | 161,560 | +27.1% | 0.00% | – |
| Q2 2023 | $605,139 | +4.3% | 127,130 | +24.9% | 0.00% | – |
| Q1 2023 | $580,260 | -80.9% | 101,800 | -66.3% | 0.00% | -100.0% |
| Q4 2022 | $3,045,162 | +33.5% | 301,800 | +196.5% | 0.00% | 0.0% |
| Q3 2022 | $2,281,000 | -35.1% | 101,800 | -28.2% | 0.00% | -50.0% |
| Q2 2022 | $3,514,000 | -36.1% | 141,790 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $5,503,000 | -33.6% | 141,947 | +0.3% | 0.00% | -33.3% |
| Q4 2021 | $8,284,000 | -1.3% | 141,590 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $8,392,000 | -32.0% | 141,590 | -0.4% | 0.00% | -40.0% |
| Q2 2021 | $12,341,000 | +15.9% | 142,190 | +10.1% | 0.01% | 0.0% |
| Q1 2021 | $10,650,000 | +18.1% | 129,170 | +30.2% | 0.01% | +25.0% |
| Q4 2020 | $9,020,000 | +146.9% | 99,200 | +8.5% | 0.00% | +100.0% |
| Q3 2020 | $3,653,000 | +24.1% | 91,400 | +6.5% | 0.00% | 0.0% |
| Q2 2020 | $2,944,000 | +64.3% | 85,800 | +6.3% | 0.00% | +100.0% |
| Q1 2020 | $1,792,000 | +28.5% | 80,700 | +13.2% | 0.00% | 0.0% |
| Q4 2019 | $1,395,000 | +31.1% | 71,300 | +4.1% | 0.00% | 0.0% |
| Q3 2019 | $1,064,000 | -23.5% | 68,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,391,000 | +32.4% | 68,500 | +14.5% | 0.00% | 0.0% |
| Q1 2019 | $1,051,000 | +42.0% | 59,800 | +3.6% | 0.00% | 0.0% |
| Q4 2018 | $740,000 | +6.6% | 57,700 | +35.4% | 0.00% | – |
| Q3 2018 | $694,000 | +121.7% | 42,600 | +54.3% | 0.00% | – |
| Q2 2018 | $313,000 | +192.5% | 27,600 | +150.9% | 0.00% | – |
| Q1 2018 | $107,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $11,083,330 | 2.77% |
| Redmile Group, LLC | 13,169,057 | $43,194,507 | 2.61% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 497,360 | $1,631,341 | 2.06% |
| Boxer Capital, LLC | 8,215,910 | $26,948,185 | 1.42% |
| Deep Track Capital, LP | 5,572,607 | $18,278,151 | 0.55% |
| Vestal Point Capital, LP | 2,000,000 | $6,560,000 | 0.49% |
| Bruce & Co., Inc. | 300,000 | $984,000 | 0.32% |
| Octagon Capital Advisors LP | 520,800 | $1,708,224 | 0.27% |
| Integral Health Asset Management, LLC | 850,000 | $2,788,000 | 0.26% |
| Bellevue Group AG | 4,839,779 | $15,874,475 | 0.26% |